Singh AK - Search Results

1

Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin: rationale and evidences.

Singh AK, Singh R. Singh AK, et al. Among authors: singh r. Expert Rev Clin Pharmacol. 2016 Apr;9(4):605-616. doi: 10.1586/17512433.2016.1130621. Epub 2016 Jan 8. Expert Rev Clin Pharmacol. 2016. PMID: 26652227

2

Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions.

Singh AK. Singh AK. Indian J Endocrinol Metab. 2014 Nov;18(6):753-9. doi: 10.4103/2230-8210.141319. Indian J Endocrinol Metab. 2014. PMID: 25364668 Free PMC article. Review.

3

Metformin in gestational diabetes: An emerging contender.

Singh AK, Singh R. Singh AK, et al. Among authors: singh r. Indian J Endocrinol Metab. 2015 Mar-Apr;19(2):236-44. doi: 10.4103/2230-8210.149317. Indian J Endocrinol Metab. 2015. PMID: 25729685 Free PMC article. Review.

4

Bariatric surgery and diabetes remission: Who would have thought it?

Singh AK, Singh R, Kota SK. Singh AK, et al. Among authors: singh r. Indian J Endocrinol Metab. 2015 Sep-Oct;19(5):563-76. doi: 10.4103/2230-8210.163113. Indian J Endocrinol Metab. 2015. PMID: 26425464 Free PMC article. Review.

5

Combination therapy of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: rationale and evidences.

Singh AK, Singh R. Singh AK, et al. Among authors: singh r. Expert Rev Clin Pharmacol. 2016;9(2):229-40. doi: 10.1586/17512433.2016.1123616. Epub 2015 Dec 25. Expert Rev Clin Pharmacol. 2016. PMID: 26589238 Review.

6

Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress.

Singh AK, Singh R. Singh AK, et al. Among authors: singh r. Indian J Endocrinol Metab. 2015 Nov-Dec;19(6):731-43. doi: 10.4103/2230-8210.167548. Indian J Endocrinol Metab. 2015. PMID: 26693422 Free PMC article. Review.

7

Sodium-glucose co-transporter-2 inhibitors as add-on therapy to insulin: rationale and evidences.

Singh AK, Singh R. Singh AK, et al. Among authors: singh r. Expert Rev Clin Pharmacol. 2016;9(3):409-18. doi: 10.1586/17512433.2016.1131121. Epub 2016 Jan 5. Expert Rev Clin Pharmacol. 2016. PMID: 26732230 Review.

8

Dipeptidyl peptidase-4 inhibitors or sodium glucose co-transporter-2 inhibitors as an add-on to insulin therapy: A comparative review.

Singh AK, Singh R. Singh AK, et al. Among authors: singh r. Indian J Endocrinol Metab. 2016 Jan-Feb;20(1):32-42. doi: 10.4103/2230-8210.172278. Indian J Endocrinol Metab. 2016. PMID: 26904466 Free PMC article. Review.

9

Is gliclazide a sulfonylurea with difference? A review in 2016.

Singh AK, Singh R. Singh AK, et al. Among authors: singh r. Expert Rev Clin Pharmacol. 2016 Jun;9(6):839-51. doi: 10.1586/17512433.2016.1159512. Epub 2016 Mar 15. Expert Rev Clin Pharmacol. 2016. PMID: 26924475 Review.

10

Sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors combination therapy in type 2 diabetes: A systematic review of current evidence.

Singh AK, Singh R. Singh AK, et al. Among authors: singh r. Indian J Endocrinol Metab. 2016 Mar-Apr;20(2):245-53. doi: 10.4103/2230-8210.176353. Indian J Endocrinol Metab. 2016. PMID: 27042423 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,632 results

Search Page